GitLife Biotech develops digital infrastructure for synthetic biology, helping biotech teams trace, protect and commercialise engineered biological assets. Its platform combines CellRepo, a version-controlled bioasset registry, with Genosignatures, encrypted DNA barcodes that link physical biological materials to secure digital records. The company supports strain management, provenance tracking, intellectual property protection, licensing oversight, biosecurity and auditable collaboration across research and commercial teams. Serving biotechnology, life sciences and engineering biology organisations, GitLife Biotech aims to make biological innovation more structured, secure, shareable and commercially valuable.
This is a company profile stub. Create an account to claim your profile.
